Reply to: "Evidence supporting a beneficial role of vitamin D in chronic hepatitis C"

J Hepatol. 2015 Aug;63(2):531-2. doi: 10.1016/j.jhep.2015.04.012. Epub 2015 Apr 18.

Authors

Matthew T Kitson¹, Christoph Sarrazin², Pierluigi Toniutto³, Stuart Keith Roberts⁴

Affiliations

¹ The Alfred Hospital, Department of Hepatology, Melbourne, Victoria 3004, Australia.
² J.W. Goethe-University Hospital, Medizinische Klinik 1, Frankfurt 60590, Germany.
³ Internal Medicine, University of Udine, Department of Medical Sciences Clinical & Experimental, Udine, Italy.
⁴ The Alfred Hospital, Department of Hepatology, Melbourne, Victoria 3004, Australia. Electronic address: s.roberts@alfred.org.au.

PMID: 25899534
DOI: 10.1016/j.jhep.2015.04.012

No abstract available

Publication types

Letter
Comment

MeSH terms

Hepacivirus / physiology*
Hepatitis C, Chronic / drug therapy*
Humans
Interferon-alpha / therapeutic use*
Polyethylene Glycols / therapeutic use*
Ribavirin / therapeutic use*
Vitamin D / blood*

Substances

Interferon-alpha
Vitamin D
Polyethylene Glycols
Ribavirin